Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer

K. R. Haisley, K. D. Hart, N. Nabavizadeh, K. G. Bensch, Gina Vaccaro, C. R. Thomas, P. H. Schipper, J. G. Hunter, James Dolan

Research output: Contribution to journal › Article › peer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences